1i5v

From Proteopedia

(Difference between revisions)
Jump to: navigation, search

OCA (Talk | contribs)
(New page: 200px<br /><applet load="1i5v" size="450" color="white" frame="true" align="right" spinBox="true" caption="1i5v" /> '''SOLUTION STRUCTURE OF 2-(PYRIDO[1,2-E]PURIN-...)
Next diff →

Revision as of 01:32, 25 November 2007


1i5v

Drag the structure with the mouse to rotate

SOLUTION STRUCTURE OF 2-(PYRIDO[1,2-E]PURIN-4-YL)AMINO-ETHANOL INTERCALATED IN THE DNA DUPLEX D(CGATCG)2

Overview

The solution structure of the complex formed between d(CGATCG)(2) and, 2-(pyrido[1,2-e]purin-4-yl)amino-ethanol, a new antitumor drug under, design, has been resolved using NMR spectroscopy and restrained molecular, dynamic simulations. The drug molecule intercalates between each of the, CpG dinucleotide steps with its side chain lying in the minor groove., Analysis of NMR data establishes a weak stacking interaction between the, intercalated ligand and the DNA bases; however, the drug/DNA affinity is, enhanced by a hydrogen bond between the hydroxyl group of the end of the, intercalant side chain and the amide group of guanine G6. Unrestrained, molecular dynamic simulations performed in a water box confirm the, stability of the intercalation model. The structure of the intercalated, complex enables insight into the structure-activity relationship, allowing, rationalization of the design of new antineoplasic agents.

About this Structure

1I5V is a Protein complex structure of sequences from [1] with PPZ as ligand. Full crystallographic information is available from OCA.

Reference

Solution structure of 2-(pyrido[1,2-e]purin-4-yl)amino-ethanol intercalated in the DNA duplex d(CGATCG)2., Favier A, Blackledge M, Simorre JP, Crouzy S, Dabouis V, Gueiffier A, Marion D, Debouzy JC, Biochemistry. 2001 Jul 31;40(30):8717-26. PMID:11467931

Page seeded by OCA on Sun Nov 25 03:39:39 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools